Pages that link to "Q114293343"

The following pages link to Karl-Anton Kreuzer (Q114293343):

Displaying 20 items.

• Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromes (Q24186133) (← links)
• Low dose cytarabine monotherapy for acute myeloid leukaemia (Q24186270) (← links)
• Hypomethylating agents for patients with myelodysplastic syndrome (Q24186276) (← links)
• Hypomethylating agents for adult patients with acute myeloid leukaemia (Q24186284) (← links)
• Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (APL)) (Q24188096) (← links)
• Thrombopoietin mimetics for patients with myelodysplastic syndromes (Q24198060) (← links)
• Hypomethylating agents for adult patients with acute myeloid leukaemia (Q24234645) (← links)
• Low dose cytarabine monotherapy for acute myeloid leukaemia (Q24234680) (← links)
• Low dose cytarabine monotherapy for myelodysplastic syndromes (Q24234789) (← links)
• Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromes (Q24234828) (← links)
• Hypomethylating agents for patients with myelodysplastic syndrome (Q24236549) (← links)
• Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype (Q34225646) (← links)
• Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group (Q36508333) (← links)
• Determination of alpha-1 acid glycoprotein in patients with Ph chronic myeloid leukemia during the first 13 weeks of therapy with STI571. (Q43978185) (← links)
• Imatinib in Philadelphia chromosome-positive chronic phase CML patients: molecular and cytogenetic response rates and prediction of clinical outcome (Q44524712) (← links)
• Pharmacokinetics and cellular uptake of imatinib and its main metabolite CGP74588. (Q44681598) (← links)
• A novel hierarchical prognostic model of AML solely based on molecular mutations (Q45756753) (← links)
• Sorafenib in combination with intensive chemotherapy in elderly patients with acute myeloid leukemia: results from a randomized, placebo-controlled trial (Q47903403) (← links)
• Kinetics of stem cell engraftment and clearance of leukaemia cells after allogeneic stem cell transplantation with reduced intensity conditioning in chronic myeloid leukaemia (Q77067722) (← links)
• Anti-CD20 immunotherapy as a bridge to tolerance, after allogeneic stem cell transplantation for patients with chronic lymphocytic leukaemia: results of the CLLX4 trial (Q88023820) (← links)